Cardiovascular regulation and lipoprotein profile during administration of co-dergocrine in essential hypertension

scientific article published in January 1989

Cardiovascular regulation and lipoprotein profile during administration of co-dergocrine in essential hypertension is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF00609182
P698PubMed publication ID2721537

P2093author name stringP Weidmann
D E Uehlinger
M P Gnaedinger
P2860cites workCorrection of altered noradrenaline reactivity in essential hypertension by indapamideQ36783932
Antihypertensive treatment and serum lipoproteinsQ39393667
Quantitation of the major apoproteins of human high density lipoproteins by solid phase radioimmunoassayQ40158965
Investigations on the hypotensive effect of the hydrogenated ergot alkaloidsQ41859004
Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.Q53711591
Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertensionQ67446775
Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium/volume state in normal manQ67658384
Radioimmunoassay of aldosterone in crude plasma extractsQ67816473
Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole rangeQ67868312
The renin system: Variations in man measured by radioimmunoassay or bioassayQ68687899
Peripheral dopamine receptors in the antihypertensive action of dihydroergotoxine in humansQ69692578
Cardiovascular regulation during administration of co-dergocrine to normal subjectsQ70029064
Dihydroergotoxine decreases blood pressure in spontaneously hypertensive rats by interacting with peripheral dopamine receptorsQ70076788
Antihypertensive mechanism of diuretic treatment with chlorthalidone. Complementary roles of sympathetic axis and sodiumQ70252348
Calcium and blood pressure regulation in normal and hypertensive subjectsQ70263223
Cardiovascular counterregulation during sympathetic inhibition in normal subjects and patients with mild hypertensionQ70308152
A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranololQ70398769
Correction of cardiovascular hypersensitivity to norepinephrine by potassium supplementation in normotensive members of hypertensive families and patients with essential hypertensionQ70979926
Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidoneQ71192162
Steady state bioavailability of a new oral formulation of Hydergine in geriatric patientsQ71324301
[Co-dergocrinmesylate in elderly hypertensive patients]Q71635935
Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390Q72579630
Observations on the action of the hydrogenated alkaloids of the ergotoxine group on the circulation in manQ75704419
[Comparative studies on the renal clearance of Na-Cr2Cr51 ethylenediaminetetraacetate, inulin and sodium thiosulfate in humans]Q93801437
P433issue2
P304page(s)119-125
P577publication date1989-01-01
P1433published inEuropean Journal of Clinical PharmacologyQ1376707
P1476titleCardiovascular regulation and lipoprotein profile during administration of co-dergocrine in essential hypertension
P478volume36

Reverse relations

cites work (P2860)
Q68011333Clinical pharmacokinetics of the nifedipine/co-dergocrine combination in impaired liver and renal function
Q44789416Effects of adrenaline and noradrenaline on clearance of triacylglycerol-rich lipoproteins from plasma: studies with chylomicron-like lipid emulsions in rats